Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Webinar Co-Hosted with Bioanalysis Zone
Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant? BioAgilytix’s Global CSO, Dr. Arno Kromminga addresses this subject and more.
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
4 Days Agoview on linkedin
Join Dr. Arno Kromminga and Dr. Lydia Michaut on 14 May at 15:00 CEST for their webinar, “Immunogenicity assessment of gene therapy compounds: discussion on current and future concepts”. Register with Bioanalysis Zone to hold your spot today! https://lnkd.in/ee5QWZ8
4 Days Agoview on linkedin
BioAgilytix’s President & CEO, Jim Datin, recently discussed how BioAgilytix is supporting the exciting trends and projected growth in large molecule development. Visit our resource center to hear the full podcast or read the transcript: https://lnkd.in/euG6t2Z
5 Days Agoview on linkedin
Flow cytometry is an ideal platform for many applications involving the study of complex cell populations. In the first blog of our new “The Fit for Flow” series, we discuss what makes flow cytometry the platform of choice for receptor occupancy (RO) studies: https://lnkd.in/eQTQaMx
April 17, 2019The Fit for Flow Cytometry, Part 1: Ideal for Receptor Occupancy Assessment
April 12, 2019BioAgilytix Team Q&A: Meet Corinna Fiorotti, Scientific Officer and Key Accounts Director
March 26, 2019BioAgilytix Announces Promotion of Corinna Fiorotti, Ph.D. to Scientific Officer and Key Accounts Director
February 7, 2019BioAgilytix Welcomes Lydia Michaut, Ph.D. to Team as Scientific Officer
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.
